This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers (preprint)
medrxiv; 2020.
预印本
在 英语
| medRxiv | ID: ppzbmed-10.1101.2020.12.23.20248789
ABSTRACT
Objective:
To characterize the SARS-CoV-2 testing cascade and associated barriers in three US states.Methods:
We recruited participants from Florida, Illinois, and Maryland (~1000/state) for an online survey September 16 - October 15, 2020. The survey covered demographics, COVID-19 symptoms, and experiences around SARS-CoV-2 PCR testing in the prior 2 weeks. Logistic regression was used to analyze associations with outcomes of interest.Results:
Overall, 316 (10%) of 3,058 respondents wanted/needed a test in the two weeks prior to the survey. Of these, 166 (53%) were able to get tested and 156 (94%) received results; 53% waited 8 or more days to get results from when they wanted/needed a test. There were no significant differences by state. Among those wanting/needing a test, getting tested was significantly less common among men (aOR 0.46) and those reporting black race (aOR 0.53) and more common in those reporting recent travel (aOR 3.35).Conclusions:
There is an urgent need for a national communication strategy on who should get tested and where one can get tested. Additionally, measures need to be taken to improve access and reduce turn-around-time.相关文档
MEDLINE
...
LILACS
LIS